Michael T. Sapko1, Jonathan C. Javitt1,2
1NRx Pharmaceuticals
2Johns Hopkins University
Keywords: D-cycloserine, lurasidone, NMDA receptor, chronic pain, chronic pain-induced depression
Competing Interests: MTS and JCJ are consultants to NRx Pharmaceuticals, Inc. JCJ owns equity in NRx Pharmaceuticals, Inc.
Funding: Preparation of this manuscript was funded by NRx Pharmaceuticals, Inc.